Recent Quotes
My Watchlist
Indicators
Local Stocks
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Disc Medicine, Inc. - Common Stock (NQ:IRON)

66.23 +0.67 (+1.01%)
Streaming Delayed Price Updated: 2:26 PM EST, Feb 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Disc Medicine, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
Disc Medicine Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
From Disc Medicine Inc
Via GlobeNewswire
News headline image
Disc Medicine Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants
From Disc Medicine Inc
Via GlobeNewswire
News headline image
Expert Ratings for Disc Medicine ↗
 
Via Benzinga
News headline image
Why Shares of Disc Medicine Opco Climbed This Week ↗
The company's shares rose after analysts maintained their buy ratings for the stock. 
Via The Motley Fool
News headline image
Expert Ratings for Disc Medicine ↗
 
Via Benzinga
News headline image
Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
From Disc Medicine Inc
Via GlobeNewswire
News headline image
Why Asset Entities Shares Are Trading Higher By 142%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers Asset Entities Inc. (NASDAQ: ASST) shares jumped 142% to $2.79 after the company announced the development of an AI bot as part of its AE360DDM suite of services on Discord. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 12, 2023 ↗
 
Via Benzinga
News headline image
Crude Oil Down Over 1%; Planet Labs PBC Shares Tumble ↗
U.S. stocks traded higher toward the end of trading, with Dow Jones gaining around 50 points on Friday. The Dow traded up 0.14% to 33,882.18 while the NASDAQ rose 0.35% to 13,284.55. The S&P 500, also... 
Via Benzinga
News headline image
Why Are Disc Medicine Shares Trading Higher Today ↗
Disc Medicine Inc (NASDAQ: IRON) presented preliminary findings from its ongoing Phase 2 BEACON trial of bitopertin for erythropoietic protoporphyria (EPP) and X-linked protoporphyria (XLP) at the... 
Via Benzinga
News headline image
Why American Software Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Gainers Advanced Health Intelligence Ltd. (NASDAQ: AHI) shares jumped 144.5% to $0.7827. 
Via Benzinga
News headline image
Dow Edges Lower; Sientra Shares Spike Higher ↗
U.S. stocks traded pared some gains midway through trading, with Dow Jones turning lower on Friday. The Dow traded down 0.07% to 33,810.44 while the NASDAQ rose 0.17% to 13,260.91. The S&P 500, also... 
Via Benzinga
News headline image
Why Perfectly Rated Disc Medicine, With A 275% Move This Year, Just Put Up Another Big Gain ↗
The company is testing a treatment for patients with a disease that causes sunlight intolerance. 
Via Investor's Business Daily
News headline image
Tesla, Adobe, Mission Produce And Other Big Stocks Moving Higher On Friday ↗
U.S. stocks traded higher, with the Dow Jones rising around 100 points on Friday. Here are some big stocks recording gains in today’s session. Braze, Inc. (NASDAQ: BRZE) shares climbed 20.4% to $ 40.82... 
Via Benzinga
News headline image
Disc Presents Positive Initial Data from Phase 2 BEACON Trial of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP) at European Hematology Association (EHA) 2023 Congress
From Disc Medicine Inc
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2023 ↗
 
Via Benzinga
News headline image
Disc Medicine to Participate in the Jefferies Healthcare Conference
From Disc Medicine Inc
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 17, 2023 ↗
 
Via Benzinga
News headline image
Disc Medicine Reports First Quarter 2023 Financial Results and Provides Business Update
From Disc Medicine Inc
Via GlobeNewswire
News headline image
Disc Medicine Announces Presentation of Initial Data from Phase 2 BEACON Trial in Patients with Erythropoietic Protoporphyria (EPP) at European Hematology Association (EHA) 2023 Congress
From Disc Medicine Inc
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For April 28, 2023 ↗
 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For April 21, 2023 ↗
 
Via Benzinga
News headline image
Disc Medicine to Participate in H.C. Wainwright BioConnect Investor Conference
From Disc Medicine Inc
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2023 ↗
 
Via Benzinga
News headline image
Disc Medicine to Host Disease Webinar with KOLs on Erythropoietic Protoporphyria (EPP)
From Disc Medicine Inc
Via GlobeNewswire
News headline image
Why Y-mAbs Therapeutics Shares Are Trading Higher By 50%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Gainers Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) climbed 49.9% to $4.93 after the company posted a profit for the fourth quarter. 
Via Benzinga
News headline image
Ensysce Biosciences, AST SpaceMobile, IGM Biosciences And Other Big Stocks Moving Lower On Friday ↗
U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Friday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
News headline image
Disc Medicine Reports Full Year 2022 Financial Results and Provides Business Update
From Disc Medicine Inc
Via GlobeNewswire
News headline image
Why Heron Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket ↗
Gainers Bird Global, Inc. (NYSE: BRDS) shares rose 58.7% to $0.2250 in pre-market trading after gaining more than 17% on Thursday. Bird announced plans to expand across Greater Toronto area this... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 23, 2023 ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.